BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients

被引:6
作者
Lopez-Munoz, Eunice [1 ]
Hernandez-Zarco, Adelina [1 ]
Garcia-Hernandez, Normand [1 ]
Alvarado-Cabrero, Isabel [2 ]
Zarco-Espinosa, Gelasio [3 ]
Salamanca-Gomez, Fabio
Arenas-Aranda, Diego [1 ]
机构
[1] Hosp Pediat Mexico City, Unidad Invest Med Genet Humana, Ctr Med Nacl Siglo XXI CMN S XXI, Inst Mexicano Seguro Social IMSS, Mexico City 06720, DF, Mexico
[2] Hosp Oncol, Serv Patol, CMN SXXI, IMSS, Mexico City 06720, DF, Mexico
[3] Hosp Oncol, Serv Tumores Mama, CMN S XXI, IMSS, Mexico City 06720, DF, Mexico
关键词
BIK/NBK; Estrogen receptor; Breast cancer; ENDOPLASMIC-RETICULUM BIK; BCL-2 PROTEIN FAMILY; CELL-DEATH; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; MITOCHONDRIAL APOPTOSIS; PROTEASOME INHIBITORS; AROMATASE INHIBITORS; BH3-ONLY PROTEIN; DRUG-RESISTANCE;
D O I
10.1007/s12094-012-0845-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study is to determine the association between the BIK/NBK gene expression and estrogen receptor alpha expression. We determined the association of BIK/NBK gene expression by real time quantitative reverse transcription polymerase chain reaction and estrogen receptor alpha expression by immunohistochemistry in samples of breast cancer tissue. We found a statistically significant correlation of BIK/NBK gene expression with the estrogen receptor alpha expression (rho = 0.751, p = 0.004). For verify differences of BIK/NBK gene expression among ER alpha+ and ER alpha- breast cancer tissues, Mann-Whitney U test was performed, obtaining significant differences. BIK/NBK gene expression may have important clinical implications and provide predictive, prognostic or therapeutic marker in breast cancer patients according to the estrogen receptor alpha expression.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [21] Vascular mimicry: A potential therapeutic target in breast cancer
    Chavoshi, Hadi
    Poormolaie, Neda
    Vahedian, Vahid
    Kazemzadeh, Hamid
    Mir, Amirabbas
    Nejabati, Hamid Reza
    Behroozi, Javad
    Isazadeh, Alireza
    Hajezimian, Saba
    Nouri, Mohammad
    Maroufi, Nazila Fathi
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 234
  • [22] Argininosuccinate lyase is a potential therapeutic target in breast cancer
    Huang, Hau-Lun
    Chen, Wei-Ching
    Hsu, Hu-Ping
    Cho, Chien-Yu
    Hung, Yu-Hsuan
    Wang, Chih-Yang
    Lai, Ming-Derg
    ONCOLOGY REPORTS, 2015, 34 (06) : 3131 - 3139
  • [23] Dysregulation of HOX as a Potential Therapeutic Target in Breast Cancer
    Lee, Ji-Yeon
    Kim, Myoung Hee
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (25) : 5084 - 5097
  • [24] Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer
    Nadler, Y.
    Gonzalez, A. M.
    Camp, R. L.
    Rimm, D. L.
    Kluger, H. M.
    Kluger, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 466 - 473
  • [25] Progesterone receptor expression is a marker for early stage breast cancer: Implications for progesterone receptor as a therapeutic tool and target
    Coyle, Yvonne M.
    Xie, Xian-Jin
    Hardy, Daniel B.
    Ashfaq, Raheela
    Mendelson, Carole R.
    CANCER LETTERS, 2007, 258 (02) : 253 - 261
  • [26] Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer
    Bai, J.
    Yong, H. M.
    Chen, F. F.
    Mei, P. J.
    Liu, H.
    Li, C.
    Pan, Z. Q.
    Wu, Y. P.
    Zheng, J. N.
    ANNALS OF ONCOLOGY, 2013, 24 (08) : 2016 - 2022
  • [27] Identification of endothelial selectin as a potential prognostic marker in breast cancer
    Zhang, Wei
    Zuo, Zhichao
    Huang, Xiangyang
    Liu, Junjie
    Jin, Guanqiao
    Su, Danke
    ONCOLOGY LETTERS, 2018, 15 (06) : 9908 - 9916
  • [28] Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapy
    Yun, Wen-jing
    Xue, Hang
    Yang, Ning
    Xiao, Li-jun
    Sun, Hong-zhi
    Zheng, Hua-chuan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (10) : 3042 - 3056
  • [29] Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapy
    Wen-jing Yun
    Hang Xue
    Ning Yang
    Li-jun Xiao
    Hong-zhi Sun
    Hua-chuan Zheng
    Clinical and Translational Oncology, 2023, 25 : 3042 - 3056
  • [30] Circulating tumor cells as prognostic marker in metastatic breast cancer
    Andreopoulou, Eleni
    Cristofanilli, Massimo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 171 - 177